Department of Social Medicine and Public Health, Faculty of Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria - Institute of Rare Disease, Plovdiv, Bulgaria.
ServizioFormazione, Istituto Superiore di Sanità, Rome, Italy.
Ann Ist Super Sanita. 2019 Jul-Sep;55(3):270-275. doi: 10.4415/ANN_19_03_13.
Distribution of public spending on health depends on a variety of factors, from disease burden and system priorities to organisational aspects and costs. Nowadays, virtually all health care systems face serious sustainability challenges. This is particularly true for rare diseases, where priority setting involves complex and often controversial value-laden choices.
The theoretical framework underlying the approach of this work is based upon the State of Health in the EU, a two-year initiative undertaken by the European Commission and developed in cooperation with the Organisation for Economic Co-operation and Development and the European Observatory on Health Systems and Policies.
The 2017 report identified five cross-cutting sustainability issues: health promotion and disease prevention, primary care, integrated care, health workforce planning and forecasting, person-centred health data.Implications and recommendations. Rare diseases have been one of the priorities of the Community's programmes for research and development. The EU has stimulated a series of actions in the field of rare diseases. These project activities could set up the practical cooperation and come up with the knowledge to translate and to work on the identified five key challenges of EU Member States health systems' sustainability and resilience.
公共卫生支出的分配取决于多种因素,从疾病负担和系统优先事项到组织方面和成本。如今,几乎所有的医疗保健系统都面临着严重的可持续性挑战。对于罕见病来说,情况更是如此,优先事项的设定涉及到复杂且常常存在争议的价值判断。
这项工作所依据的理论框架基于欧盟的健康状况,这是欧盟委员会进行的为期两年的倡议,是与经济合作与发展组织和欧洲卫生系统和政策观察站合作开展的。
2017 年的报告确定了五个跨领域的可持续性问题:健康促进和疾病预防、初级保健、综合保健、卫生人力规划和预测、以人为本的健康数据。影响和建议。罕见病一直是欧盟研究与发展计划的优先事项之一。欧盟在罕见病领域刺激了一系列行动。这些项目活动可以建立实际合作,并提供知识,以应对欧盟成员国卫生系统可持续性和弹性所面临的五个关键挑战。